APMD

16.0906.70%
LG

Lawrence G. Miller

Founder & Vice Chair of the Board

Dr. Lawrence G. Miller, also known as Larry, MD, MPH, is Vice Chair of the Board of Apnimed, Inc. from June 2, 2026 and serves as its Director from January 2018 and served as its Chief Executive Officer until June 2, 2026. Dr. Miller serves as Independent Director of ZWI Therapeutics, Inc. since January 2024. He served as Venture Partner at Sanderling Ventures since 2019. He founded PanGenX, Inc. in 2009 and serves as its Scientific Advisor. Dr. Miller serves as a Director of PatientKeeper Inc. He serves as Director of Relay Technology Management, Inc. He is Co-Founder of Apnimed, Inc. and was its Chairman and served as its President. Dr. Miller is the Founder of Activate Networks, Inc. and served as its Chairman, Chief Executive Officer and President. He served as an Operating Partner at Glen Ventures Management, Inc. till April 2018. He was a Founding Partner of Mediphase Venture Partners. He joined Mediphase on January 1, 2000. He has invested in more than 25 private companies in life sciences/health care. Previously, he was co-founder and CEO of Macrolide Pharmaceuticals, Inc. fHe has consulted extensively for major pharmaceutical companies, including Pfizer, Roche, Upjohn and Boehringer Ingelheim. He founded PharMetrics, Inc., Optio Research and ImpactRx, Inc. Dr. Miller served as a Senior Vice President at Hambrecht and Quist Capital Management in Boston from 1997 to 1999, where he was responsible for evaluating all private equity investments. Prior to this, he served as an Executive Vice President and a Director of Internal Operations at Avicenna Systems Corp. from 1996 to 1997. From 1990 to 1996, Dr. Miller served as a Vice President at HPR, Inc. as its underwent dramatic growth and a successful initial public offering in 1995. He began his efforts in health care information technology as a Senior Scientist at Health Data Institute Inc. from 1985 to 1987. He served as the Chairman of the Board at Tetraphase Pharmaceuticals, Inc., from September 2006 to December 2011. He served as the Chairman and Director of PharMetrics, Inc. He served as a Director at Tetraphase Pharmaceuticals, Inc. since August 2006 until March 18, 2013. He served as a Director of ImpactRx, Inc. He is a Member of Mather House at Harvard College. Dr. Miller is an Adjunct Associate Professor of Pharmacology at Tufts and Instructor in Medicine at Harvard Medical School. Dr. Miller was also a Faculty Member in the Department of Pharmacology and Experimental Therapeutics at Tufts University School of Medicine in Boston. He has published more than 100 scientific papers. He received numerous awards in this field, including national awards from both major professional societies in clinical pharmacology. He is a pioneer in developing novel information approaches to healthcare data and is a Clinical Pharmacologist. Dr. Miller holds a Board certification in Internal Medicine, Pulmonary Disease and Clinical Pharmacology. He is trained as a Physician and Pharmacologist. He holds a B.A in Chemistry from Harvard College. He holds an M.D., at Harvard and completed his Clinical training at the Massachusetts General Hospital in Boston and was educated at Harvard College, Cambridge University and Harvard Medical School.

Positions